Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Kontrastverstärkter Ultraschall zur Charakterisierung von inzidentellen Leberläsionen – eine ökonomische Betrachtung im Vergleich zur Mehrphasen-Computertomografie
28
Zitationen
5
Autoren
2009
Jahr
Abstract
AIM: The aim of the study was to conduct a cost-minimization analysis of contrast-enhanced ultrasound (CEUS) compared to multi-phase computed tomography (M-CT) as the diagnostic standard for diagnosing incidental liver lesions. METHODS: Different scenarios of a cost-covering realization of CEUS in the ambulant sector in the general health insurance system of Germany were compared to the current cost situation. The absolute savings potential was estimated using different approaches for the calculation of the incidence of liver lesions which require further characterization. RESULTS: CEUS was the more cost-effective method in all scenarios in which CEUS examinations where performed at specialized centers (122.18-186.53 euro) compared to M-CT (223.19 euro). With about 40 000 relevant liver lesions per year, systematic implementation of CEUS would result in a cost savings of 4 m euro per year. However, the scenario of a cost-covering CEUS examination for all physicians who perform liver ultrasound would be the most cost-intensive approach (e. g., 407.87 euro at an average utilization of the ultrasound machine of 25 %, and a CEUS ratio of 5 %). CONCLUSION: A cost-covering realization of the CEUS method can result in cost savings in the German healthcare system. A centralized approach as proposed by the DEGUM should be targeted.
Ähnliche Arbeiten
Sorafenib in Advanced Hepatocellular Carcinoma
2008 · 12.892 Zit.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · 11.407 Zit.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 · 10.607 Zit.
Management of Hepatocellular Carcinoma: An Update Δσ
2011 · 8.112 Zit.
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 · 7.096 Zit.